The	O
candidate	O
tumour	B-Cancer
suppressor	O
protein	O
ING4	O
regulates	O
brain	B-Cancer
tumour	I-Cancer
growth	O
and	O
angiogenesis	O
.	O

Gliomas	B-Cancer
are	O
the	O
most	O
common	O
primary	B-Cancer
tumours	I-Cancer
of	O
the	O
central	B-Anatomical_system
nervous	I-Anatomical_system
system	I-Anatomical_system
,	O
with	O
nearly	O
15	O
,	O
000	O
diagnosed	O
annually	O
in	O
the	O
United	O
States	O
and	O
a	O
lethality	O
approaching	O
80	O
%	O
within	O
the	O
first	O
year	O
of	O
glioblastoma	B-Cancer
diagnosis	O
.	O

The	O
marked	O
induction	O
of	O
angiogenesis	O
in	O
glioblastomas	B-Cancer
suggests	O
that	O
it	O
is	O
a	O
necessary	O
part	O
of	O
malignant	O
progression	O
;	O
however	O
,	O
the	O
precise	O
molecular	O
mechanisms	O
underlying	O
the	O
regulation	O
of	O
brain	B-Cancer
tumour	I-Cancer
growth	O
and	O
angiogenesis	O
remain	O
unresolved	O
.	O

Here	O
we	O
report	O
that	O
a	O
candidate	O
tumour	B-Cancer
suppressor	O
gene	O
,	O
ING4	O
,	O
is	O
involved	O
in	O
regulating	O
brain	B-Cancer
tumour	I-Cancer
growth	O
and	O
angiogenesis	O
.	O

Expression	O
of	O
ING4	O
is	O
significantly	O
reduced	O
in	O
gliomas	B-Cancer
as	O
compared	O
with	O
normal	O
human	O
brain	B-Tissue
tissue	I-Tissue
,	O
and	O
the	O
extent	O
of	O
reduction	O
correlates	O
with	O
the	O
progression	O
from	O
lower	O
to	O
higher	O
grades	O
of	O
tumours	B-Cancer
.	O

In	O
mice	O
,	O
xenografts	B-Cancer
of	O
human	O
glioblastoma	B-Cancer
U87MG	I-Cancer
,	O
which	O
has	O
decreased	O
expression	O
of	O
ING4	O
,	O
grow	O
significantly	O
faster	O
and	O
have	O
higher	O
vascular	B-Multi-tissue_structure
volume	O
fractions	O
than	O
control	O
tumours	B-Cancer
.	O

We	O
show	O
that	O
ING4	O
physically	O
interacts	O
with	O
p65	O
(	O
RelA	O
)	O
subunit	O
of	O
nuclear	O
factor	O
NF	O
-	O
kappaB	O
,	O
and	O
that	O
ING4	O
regulates	O
brain	B-Cancer
tumour	I-Cancer
angiogenesis	O
through	O
transcriptional	O
repression	O
of	O
NF	O
-	O
kappaB	O
-	O
responsive	O
genes	O
.	O

These	O
results	O
indicate	O
that	O
ING4	O
has	O
an	O
important	O
role	O
in	O
brain	B-Cancer
tumour	I-Cancer
pathogenesis	O
.	O

